Physician
Mississippi Sports Medicine & Orthopaedic Center
Mississippi Sports Medicine & Orthopaedic Center was paid $1.77M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 52% of everything it billed.
33Billing provider infoMISSISSIPPI SPORTS MEDICINE & ORTHOPAEDIC CENTER
JACKSON, MS 39202
JACKSON, MS 39202
33aNPI1568415560assigned 05/19/2006
33bProvider typeOrthopaedic Surgery Physician
28Total paid$1.77M
24GClaims74,004
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Orthopaedic Surgery Physician providers in Mississippi
Rank by total paid#1 of 39
Median peer was paid$11K
This provider vs. median163×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,642 | $286K | |
| 2019 | 10,570 | $312K | |
| 2020 | 7,646 | $242K | |
| 2021 | 9,089 | $300K | |
| 2022 | 19,043 | $300K | |
| 2023 | 9,854 | $188K | |
| 2024incomplete | 5,160 | $137K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 52% | 26,356 | 21,463 | $924K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 16% | 6,220 | 5,277 | $289K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.7% | 7,666 | 6,101 | $172K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.8% | 3,395 | 1,054 | $68K |
| 73564 | 3.0% | 4,823 | 3,259 | $52K | |
| 20610 | 2.9% | 4,779 | 3,875 | $50K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.9% | 1,083 | 786 | $33K |
| 73610 | 1.7% | 2,000 | 1,465 | $29K | |
| 73030 | 1.4% | 2,766 | 2,146 | $24K | |
| 73110 | 1.1% | 1,284 | 906 | $19K | |
| 73130 | <1% | 1,019 | 778 | $17K | |
| 73630 | <1% | 1,294 | 924 | $15K |
36 more codes
| 29075 | <1% | 263 | $13K | |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 123 | $8K |
| 73100 | <1% | 418 | $8K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 3,033 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,085 | $5K |
| 73560 | <1% | 691 | $5K | |
| 99152 | <1% | 861 | $3K | |
| 73502 | <1% | 638 | $3K | |
| 20611 | <1% | 109 | $3K | |
| 73140 | <1% | 143 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 62 | $2K |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | <1% | 16 | $2K |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 72 | $2K |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 116 | $2K |
| 62323 | <1% | 86 | $1K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 103 | $1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,259 | $1K |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | <1% | 83 | $917.14 |
| 97161 | <1% | 59 | $706.07 | |
| Q4038 | Cast supplies, short leg cast, adult (11 years +), fiberglass | <1% | 40 | $618.43 |
| 29405 | <1% | 56 | $572.72 | |
| 72110 | <1% | 115 | $453.04 | |
| L3670 | Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf | <1% | 50 | $380.22 |
| L1830 | Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf | <1% | 37 | $371.64 |
| 99153 | Mod sedat endo service >5yrs | <1% | 159 | $288.40 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 70 | $271.69 |
| 73600 | <1% | 35 | $163.59 | |
| 73562 | <1% | 58 | $148.82 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 18 | $132.53 |
| 99024 | <1% | 1,033 | $117.65 | |
| 73070 | <1% | 31 | $108.21 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 44 | $49.64 |
| A4465 | Non-elastic binder for extremity | <1% | 94 | $45.36 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 88 | $21.96 |
| G8410 | Footwear evaluation performed and documented | 0% | 113 | $0.00 |
| A4565 | Slings | 0% | 58 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWARF, MEREDITH (CEO)
| Provider | Location | Paid |
|---|---|---|
| Madison Physician Surgery Center, LLC | Flowood, MS | $30K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.